Apokyn (apomorphine HCL)

Ended Awarded Last action

Contract number
36C26019N0097
Awardee
Awarding agency
Obligated
$123,250

Award facts

Contract value 100% obligated
$123,249.66 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Portland, OR 97239, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$34,586
Original award $157,836

About this award

This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to MDD US Operations, LLC, a for-profit limited liability company. The contract is a Blanket Purchase Agreement (BPA) call order for the drug APOKYN (APOMORPHINE HCL), which falls under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a firm fixed price of $123,249.66 and a completion date of September 30, 2019. The place of performance is Portland, OR 97239. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 36C26019N0097?

36C26019N0097 was awarded to MDD US Operations, LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2018.

How much is contract 36C26019N0097 worth?

The government has obligated $123,250 on 36C26019N0097.

Is contract 36C26019N0097 an order under another contract?

Yes. 36C26019N0097 is a BPA call under V797D40284-VA797P15A0008, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26019N0097 competed?

The extent of competition for 36C26019N0097 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award